Skip to content

Home Search Authors Pakistan News Saved

SciRah

SciRah does not host or store research papers. Results come live from free, official scholarly APIs, and every paper links back to its original source.

Data sources

OpenAlex
Semantic Scholar
Crossref
CORE
arXiv
PubMed

Privacy policy Terms of service

M. Zheng · SciRah

Researcher profile · Semantic Scholar

M. Zheng

Share profile

M. Zheng — researcher profile on SciRah

h-index: 5
Works: 12
Citations: 156

Most-cited papers

Phase I study of adjuvant immunotherapy with autologous tumor-infiltrating lymphocytes in locally advanced cervical cancer
He Huang, Caiping Nie, Xiu-Feng Liu, Bin Song +19 more
2022Journal of Clinical Investigation50 citations Open access
Semantic Scholar
Phase II trial of efficacy, safety and biomarker analysis of sintilimab plus anlotinib for patients with recurrent or advanced endometrial cancer
Wei Wei, X. Ban, Fan Yang, Ji-bin Li +9 more
2022Journal for ImmunoTherapy of Cancer36 citations Open access
Semantic Scholar
Anlotinib combined with TQB2450 in patients with platinum-resistant or -refractory ovarian cancer: A multi-center, single-arm, phase 1b trial
C. Lan, Jing Zhao, Fan Yang, Ying Xiong +12 more
2022Cell Reports Medicine35 citations Open access
Semantic Scholar
Impact of surgery and radiation therapy on spinal high-grade gliomas: a population-based study
Jiang Liu, M. Zheng, Wu-Yang Yang, S. Lo +1 more
2018Journal of Neuro-Oncology21 citations
Semantic Scholar
Anlotinib plus chemotherapy for T790M‐negative EGFR ‐mutant non‐sqNSCLC resistant to TKIs: A multicenter phase 1b/2 trial
Juan Li, Yuke Tian, M. Zheng, J. Ge +4 more
2022Thoracic Cancer5 citations Open access
Semantic Scholar
184MO Efficacy and safety of sintilimab plus paclitaxel and cisplatin as neoadjuvant therapy for locally advanced cervical cancer: A phase II trial
T. Wan, H. Huang, Y. Feng, M. Zheng +3 more
2022Annals of Oncology4 citations Open access
Semantic Scholar
Cost-effectiveness analysis of durvalumab as a maintenance treatment for patients with locally advanced, unresectable, stage Ⅲ nsclc in china
Xiao-Tong Jiang, Jinyu Chen, M. Zheng, Hanxue Jia
2022PLoS ONE2 citations Open access
Semantic Scholar
Anlotinib in Combination with TQB2450 in Patients with Platinum-Resistant or Platinum-Refractory Ovarian Cancer (ACTION): A Multicenter, Single-Arm, Open-Label, Phase 1b Trial
C. Lan, Jingjing Zhao, Fan Yang, Ying Xiong +12 more
2021Social Science Research Network2 citations Open access
Semantic Scholar
Anlotinib plus pemetrexed as a further treatment for patients with platinum-resistant ovarian cancer: A single-arm, open-label, phase II study.
Jueming Chen, Wei Wei, Lie Zheng, Hanzhong Li +11 more
20212 citations
Semantic Scholar
Anlotinib plus sintilimab in patients with recurrent advanced endometrial cancer: A prospective open-label, single-arm, phase II clinical trial.
Wei Wei, X. Ban, Fan Yang, Yongwen Huang +5 more
20211 citations
Semantic Scholar
A prospective clinical study of early breast cancer treated with hypofractionated simultaneous integrated boost IMRT/ VMAT after breast conservative surgery
Jiabao Ma, Yu Fan, Jinghui Xu, M. Zheng +3 more
20180 citations
Semantic Scholar
440TiPTHE HERBY STUDY: A PHASE 2 OPEN-LABEL, RANDOMIZED, MULTICENTER STUDY OF BEVACIZUMAB-BASED THERAPY IN PEDIATRIC PATIENTS WITH NEWLY DIAGNOSED HIGH-GRADE GLIOMA.
J. Grill, Darren Hargrave, P. Varlet, T. Jaspan +13 more
2014Annals of Oncology0 citations Open access
Semantic Scholar

Frequent co-authors

Invite them to SciRah by sharing their profile.

Jun-Dong Li×4
Invite
Jun-Dong Li — researcher profile on SciRah
T. Wan×3
Invite
T. Wan — researcher profile on SciRah
Wei Wei×3
Invite
Wei Wei — researcher profile on SciRah
Fan Yang×3
Invite
Fan Yang — researcher profile on SciRah

×3

Invite

Xin Huang — researcher profile on SciRah

Invite

He Huang — researcher profile on SciRah

Yan-Na Zhang×2

Invite

Yan-Na Zhang — researcher profile on SciRah

Invite

Ji-Hong Liu — researcher profile on SciRah

Invite

X. Ban — researcher profile on SciRah

Invite

Ji-bin Li — researcher profile on SciRah

Xiaqin Cheng×2

Invite

Xiaqin Cheng — researcher profile on SciRah

Yongwen Huang×2

Invite

Yongwen Huang — researcher profile on SciRah